Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 33 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureDelea, T.; Karnon, J.; Goss, P.
2005Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UKKarnon, J.; Brennan, A.; Pandor, A.; Fowkes, G.; Lee, A.; Gray, D.; Coshall, C.; Nicholls, C.; Akehurst, R.
2011Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumorsDay, F.; Karnon, J.; Rischin, D.
2012Evaluating the effects of variation in clinical practice: a risk adjusted cost-effectiveness (RAC-E) analysis of acute stroke servicesPham, C.; Karnon, J.; Caffrey, O.; Ben-Tovim, D.; Hakendorf, P.; Crotty, M.
2010Decision modeling to inform decision making: Seeing the wood for the treesKarnon, J.; Brennan, A.; Akehurst, R.
2010Medication errors - what is the best way to reduce their impact on patients' health?Karnon, J.
2012Home videophones improve direct observation in Tuberculosis treatment: a mixed methods evaluationWade, V.; Karnon, J.; Eliott, J.; Hiller, J.; Neyrolles, O.
2012A critical review of model-based economic studies of depression: modelling techniques, model structure and data sourcesHajiali Afzali, H.; Karnon, J.; Gray, J.
2010To teach or not to teach? A cost-benefit analysis of teaching in private general practiceLaurence, C.; Black, L.; Karnon, J.; Briggs, N.
2009Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus CyclophosphamideLiubao, P.; Xiaomin, W.; Chongqing, T.; Karnon, J.; Gannong, C.; Jianhe, L.; Wei, C.; Xia, L.; Junhua, C.